Hennion & Walsh Asset Management’s abrdn Life Sciences Investors HQL Stock Holding History

Hennion & Walsh Asset Management’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-28,224	Closed	-$402K	–	781
2022 Q2	$402K	Sell	28,224 -713	-2%	-$10.8K	0.02%	538
2022 Q1	$479K	Buy	28,937 +63	+0.2%	+$1.08K	0.03%	520
2021 Q4	$555K	Sell	28,874 -812	-3%	-$16.3K	0.03%	518
2021 Q3	$617K	Buy	29,686 +38	+0.1%	+$813	0.03%	461
2021 Q2	$636K	Buy	29,648 +100	+0.3%	+$2.02K	0.03%	469
2021 Q1	$582K	Buy	+29,548	New	+$609K	0.04%	476

Other funds holding HQL

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Hennion & Walsh Asset Management's HQL Position: Q3 2022 in Review

Hennion & Walsh Asset Management sold out of abrdn Life Sciences Investors (HQL) in Q3 2022, closing a stake of 28,224 shares — an estimated $402K sold.

Hennion & Walsh Asset Management first reported a position in HQL in Q1 2021 and held it in 6 quarters. The position peaked at $636K in Q2 2021. 63 funds tracked by Wall St. Rank hold HQL as of Q3 2022.

Hennion & Walsh Asset Management reported no remaining abrdn Life Sciences Investors position as of Q3 2022 after selling out during the quarter.
Hennion & Walsh Asset Management sold 28,224 abrdn Life Sciences Investors shares in Q3 2022, an estimated $402K.
Hennion & Walsh Asset Management first reported a position in abrdn Life Sciences Investors in Q1 2021 and held it in 6 quarters.
Hennion & Walsh Asset Management's abrdn Life Sciences Investors position peaked at $636K in Q2 2021.
63 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2022.

Based on Hennion & Walsh Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.